DALLAS, TX
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)RETINA FOUNDATION OF THE SOUTHWEST, founded in 1975, is a community nonprofit in the Medical Research sector that reported $7.8M in total revenue in fiscal year 2023. Revenue surged 40% from the prior year, signaling strong growth momentum.
THE MISSION OF THE RETINA FOUNDATION OF THE SOUTHWEST IS TO PREVENT VISION LOSS AND RESTORE SIGHT THROUGH INNOVATIVE RESEARCH AND TREATMENT.
STUDIES TO OPTIMIZE VISUAL OUTCOMES FOR CHILDREN WITH CONGENITAL AND EARLY-ONSET EYE CONDITIONS AND ULTIMATELY DEVELOP MORE SUCCESSFUL AND EFFECTIVE METHODS FOR EARLY SCREENING, TREATMENTS, AND...
STUDIES TO OPTIMIZE VISUAL OUTCOMES FOR CHILDREN WITH CONGENITAL AND EARLY-ONSET EYE CONDITIONS AND ULTIMATELY DEVELOP MORE SUCCESSFUL AND EFFECTIVE METHODS FOR EARLY SCREENING, TREATMENTS, AND ADHERENCE. RESEARCH INTO INNOVATIVE NEW TREATMENTS FOR INHERITED RETINAL DEGENERATIVE DISEASES, SUCH AS RETINITIS PIGMENTOSA. COLLECTING AND MAINTAINING CLINICAL AND GENETIC DATA FOR INDIVIDUALS WITH INHERITED EYE DISEASES. CONDUCT VARIOUS TYPES OF RESEARCH TO BETTER UNDERSTAND AGE-RELATED MACULAR DEGENERATION, DEVELOP WAYS TO SLOW THE PROGRESSION, AND DISCOVER BETTER TREATMENT OPTIONS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $7,846,410 | $5,584,764 | +0.4% |
| Expenses | $7,801,201 | $5,481,987 | +0.4% |
| Net Income | $45,209 | $102,777 | -0.6% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| RAJIV ANAND MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| DIANE BODDY | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MEHMET CANDAS PHD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ALEX M CENA | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| LORI DAO MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| LAURIE DOTTER CPA | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| REHAM EL-SHERAZI CPA | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| WILLIAM L HUTTON MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MARC H KLEIN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| RICHARD A MASSMAN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JAMES H MERRITT MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MICKEY MUNIR | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| EVELYN J PULLIAM | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| THERESE ROURK | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| RICHARD SCHAAR PHD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| TIA S TOMLIN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| STEVEN EISNAUGLE | TREASURER | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| LOUIS GRABOWSKY | CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| NANCY ROGERS | SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| KARL CSAKY | CHIEF EXECUTIVE AND MEDICAL OFFICER | 29.00 |
Officer
|
$429,467 | $16,736 | $446,203 |
| NATALIE GILBERT | FINANCE DIRECTOR | 39.00 |
Officer
|
$133,512 | $16,084 | $149,596 |
| NAOMI EMMETT | CFO/CBO | 40.00 |
Officer
|
$29,158 | $772 | $29,930 |
| DAVID BIRCH | SCIENTIFIC DIRECTOR | 40.00 |
Key Emp
|
$310,322 | $24,915 | $335,237 |
| EILEEN BIRCH | PEDIATRIC DIRECTOR | 40.00 |
Key Emp
|
$303,475 | $24,573 | $328,048 |
| AMY JOHNSON | CHIEF DEVELOPMENT OFFICER | 40.00 |
Highest
|
$184,713 | $18,639 | $203,352 |
| CINDY BAILLIE | OPERATIONS MANAGER | 40.00 |
Highest
|
$125,926 | $15,704 | $141,630 |
| KIRSTEN LOCKE | CLINICAL TRIALS MANAGER | 40.00 |
Highest
|
$114,390 | $15,118 | $129,508 |
| SRINIVASA SRIPATHI | LAB DIRECTOR | 36.00 |
Highest
|
$111,178 | $16,769 | $127,947 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $7,846,410 | $7,801,201 | $13,241,837 | $45,209 |
| 2022 | $5,584,764 | $5,481,987 | $13,298,686 | $102,777 |
| 2021 | $5,235,992 | $15,328,314 | $12,529,577 | $-10,092,322 |
| 2020 | $6,548,229 | $4,762,788 | $22,458,102 | $1,785,441 |
| 2019 | $5,685,137 | $4,481,395 | $21,190,220 | $1,203,742 |
| 2018 | $5,241,915 | $4,262,372 | $18,720,168 | $979,543 |
Compare RETINA FOUNDATION OF THE SOUTHWEST with other nonprofits in Texas and across the country.